isoniazid has been researched along with daunorubicin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Broughton, A; Strong, JE | 1 |
| Plempel, M | 1 |
| Adamcová, M; Gersl, V; Hrdina, R; Kaplanová, J; Klimtová, I; Mazurová, Y; Ponka, P; Simůnek, T; Sterba, M | 1 |
| Adamcova, M; Gersl, V; Kaiserova, H; Mazurova, Y; Ponka, P; Popelova, O; Potacova, A; Simunek, T; Sterba, M | 1 |
2 review(s) available for isoniazid and daunorubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Radioimmunoassay of antibiotics and chemotherapeutic agents.
Topics: Anti-Bacterial Agents; Cross Reactions; Daunorubicin; Doxorubicin; Folic Acid Antagonists; Gentamicins; Haptens; Humans; Isoniazid; Isotope Labeling; Penicillins; Pharmaceutical Preparations; Protein Binding; Radioimmunoassay; Serum Albumin, Bovine; Structure-Activity Relationship | 1976 |
6 other study(ies) available for isoniazid and daunorubicin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Action mechanism of antibacterial and antifungal drugs].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacitracin; Bacteria; Cephalosporins; Chloramphenicol; Cycloserine; Daunorubicin; Fungi; Isoniazid; Mitomycins; Nalidixic Acid; Nystatin; Penicillins; Polymyxins; Puromycin; Sulfonamides | 1967 |
Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits.
Topics: Animals; Cardiotonic Agents; Daunorubicin; Heart Ventricles; Isoniazid; Male; Myocardium; Pyridoxal; Rabbits | 2005 |
Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Daunorubicin; Heart Diseases; Iron Chelating Agents; Isoniazid; Pyridoxal; Rabbits | 2008 |